![]() ![]() 12-15 Molecular Diagnostics is in the business of developing a Point of Care, Rapid Response Diagnos. Berry have been used to analyze over 7,000 clinical samples, including blood, urine, sputum, plasma, and biopsied tissue. 12-15 Molecular Diagnostics, East Haven, Connecticut. To date, molecular diagnostics developed by Dr. Grody M.D., Ph.D., in Molecular Diagnostics, 2010 Molecular diagnostics molecular pathologygenomic medicine: It wasn’t all that long ago when these terms were unknown in the medical lexicon, and in fact would have sounded at best unintelligible to most practitioners, or at worst like oxymorons. His technologies have been used to analyze a wide range of disease states, including cancer, HIV, tuberculosis, hepatitis, influenza, transplant rejection, and malaria. Scott Berry has 10 years of experience developing molecular diagnostics in both academia and industry. Further, we have also demonstrated that simplification can ultimately unlock new functionalities in molecular analysis, thus advancing our endeavor to understand the most complex diseases, including cancer.ĭr. Thus, there is a current unmet need for simple molecular diagnostics that can be deployed in the most remote healthcare settings at minimal cost. Developing a PoC, Rapid Response Diagnostic Device for detecting between Bacterial & Viral Infections using Biofluids. Unfortunately, the complexity associated with these tests severely hinders their implementation in regions where resources are limited. 12-15 Molecular Diagnostics, Inc 82 followers on LinkedIn. Molecular diagnostics have revolutionized healthcare by enabling scientists and healthcare professions to identify disease with higher sensitivity while also elucidating specific mechanisms of disease progression. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |